parathyroid hormone analogue
Teriparatide
Answer
Teriparatide is authorised or registered in the US, the EU, the UK, Canada, Australia, Switzerland, Brazil, Serbia, Singapore and Turkey: 10 of the 10 registers read. Highest trial phase: Phase 4 (after approval). It has 185 registered trials, 17 of them running. Brand names on the FDA label register: Teriparatide, Bonsity and Forteo.
RegulatorTrial register10 regulators' registers, read 2026-09-03 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03
Not medical, legal or regulatory advice.
185 trials by status
Trial registerClinicalTrials.gov and EU CTIS · read 2026-10-03 · 56 trials have posted results
Trials first submitted per year
Trial registerClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 139 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).
Status by jurisdiction
World map| Where | Status | Register | Read |
|---|---|---|---|
| United States | FDA-approved | FDA, openfda | 2026-10-03 |
| European Union | Authorised | EMA, ema | 2026-10-03 |
| United Kingdom | Authorised | MHRA, uk-mhra | 2026-10-03 |
| Canada | Authorised | Health Canada, ca-dpd | 2026-10-03 |
| Australia | Registered | TGA, au-artg | 2026-10-03 |
| Switzerland | Authorised | Swissmedic, ch-swissmedic | 2026-10-03 |
| Brazil | Registado | ANVISA, br-anvisa | 2026-10-03 |
| Serbia | Authorised | ALIMS, rs-alims | 2026-09-03 |
| Singapore | Registered | HSA, sg-hsa | 2026-09-03 |
| Turkey | Ruhsatli | TITCK, tr-titck | 2026-09-03 |
An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.
Side effects
Trial registerCHANGE ALERTS
Get an email when this changes
One email when the status of Teriparatide changes on the register. You confirm your address first.
REGISTERED TRIALS
Newest 10 of 185 trials
| NCT03994172 | Novel Combination Therapy for Osteoporosis in Men completed · register updated 2026-09-03 |
|---|---|
| NCT07242612 | Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis completed · register updated 2026-08-13 |
| NCT06164795 | Sequential Therapies After Osteoanabolic Treatment currently recruiting participants · register updated 2026-07-22 |
| NCT07497503 | A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants currently recruiting participants · register updated 2026-07-16 |
| NCT03735537 | Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid completed · register updated 2026-06-11 |
| NCT01293292 | Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action completed · register updated 2026-05-19 |
| NCT03770338 | Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery running, but no longer enrolling · register updated 2026-05-14 |
| NCT05151484 | Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover running, but no longer enrolling · register updated 2026-05-14 |
| NCT07579936 | A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens currently recruiting participants · register updated 2026-05-12 |
| NCT01155232 | Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis running, but no longer enrolling · register updated 2026-05-11 |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.